tm logo

Monitor this mark

View On USPTO

ERNAMVI
Live/Registered
REGISTERED

on 27 Jun 2023

Last Applicant/ Owned by

Sanofi

46 avenue de la Grande Armée

Paris

FR

75017

Serial Number

97555587 filed on 19th Aug 2022

Registration Number

7093483 registered on 27th Jun 2023

in the Principal Register

Correspondent Address

Karen Lim

Karen Lim

151 WEST 42ND ST., 17TH FL

NEW YORK NY 10036

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ERNAMVI

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, inflammation, and inflammatory diseases and disorders; anti-cancer preparations

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of autoimmune diseases and disorders, inflammation, and inflammatory diseases and disorders; anti-cancer preparations

Mark Details

Serial Number

No 97555587

Mark Type

No Service/Collective Mark

Attorney Docket Number

No SYN 2210120

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
27th Jun 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
27th Jun 2023REGISTERED-PRINCIPAL REGISTER
11th Apr 2023PUBLISHED FOR OPPOSITION
11th Apr 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Mar 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03rd Mar 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
03rd Mar 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
03rd Mar 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
02th Mar 2023APPROVED FOR PUB - PRINCIPAL REGISTER
23rd Feb 2023ASSIGNED TO EXAMINER